24 November 2017
News and Views
Links and Services
April's issue of the European Journal of Gastroenterology & Hepatology evaluates clinical, biological, and endoscopic responses to adalimumab in antitumor necrosis factor-naive Crohn’s disease.
Endoscopic healing and clinical remission are important parameters to evaluate therapeutic effica
Email this page to a colleague
GastroHep.com is a Blackwell Publishing registered trademark
© 2017 Wiley-Blackwell and GastroHep.com and contributors